Commercial Pharmaceutical Supply – Fluticasone Propionate Nasal Spray

The contract requires the supply of 52 units of FDA-approved Fluticasone Propionate Nasal Spray, a commercially available pharmaceutical product that meets all required NDC and NSN specifications. This subcontract is issued under the auspices of the Defense Logistics Agency, a component of the Department of Defense, and falls under the NAICS code 325412, which pertains to pharmaceutical and medicine manufacturing. The solicitation was posted on August 5, 2026, and the contract is designated as a subcontract without any set-aside designation. The product must comply fully with federal pharmaceutical standards and is intended for delivery in accordance with DLA supply protocols, though specific place of performance and point of contact details are not provided. The contract is accessible via the DIBBS system under the referenced award and delivery numbers.